Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Newest Articles
    • Current Issue
    • Methods & Resources
    • Author Interviews
    • Archive
    • Subjects
  • Collections
  • Submit
    • Submit a Manuscript
    • Author Guidelines
    • License, Copyright, Fee
    • FAQ
    • Why submit
  • About
    • About Us
    • Editors & Staff
    • Board Members
    • Licensing and Reuse
    • Reviewer Guidelines
    • Privacy Policy
    • Advertise
    • Contact Us
    • LSA LLC
  • Alerts
  • Other Publications
    • EMBO Press
    • The EMBO Journal
    • EMBO reports
    • EMBO Molecular Medicine
    • Molecular Systems Biology
    • Rockefeller University Press
    • Journal of Cell Biology
    • Journal of Experimental Medicine
    • Journal of General Physiology
    • Journal of Human Immunity
    • Cold Spring Harbor Laboratory Press
    • Genes & Development
    • Genome Research

User menu

  • My alerts

Search

  • Advanced search
Life Science Alliance
  • Other Publications
    • EMBO Press
    • The EMBO Journal
    • EMBO reports
    • EMBO Molecular Medicine
    • Molecular Systems Biology
    • Rockefeller University Press
    • Journal of Cell Biology
    • Journal of Experimental Medicine
    • Journal of General Physiology
    • Journal of Human Immunity
    • Cold Spring Harbor Laboratory Press
    • Genes & Development
    • Genome Research
  • My alerts
Life Science Alliance

Advanced Search

  • Home
  • Articles
    • Newest Articles
    • Current Issue
    • Methods & Resources
    • Author Interviews
    • Archive
    • Subjects
  • Collections
  • Submit
    • Submit a Manuscript
    • Author Guidelines
    • License, Copyright, Fee
    • FAQ
    • Why submit
  • About
    • About Us
    • Editors & Staff
    • Board Members
    • Licensing and Reuse
    • Reviewer Guidelines
    • Privacy Policy
    • Advertise
    • Contact Us
    • LSA LLC
  • Alerts
  • Follow LSA on Bluesky
  • Follow lsa Template on Twitter
Research Article
Transparent Process
Open Access

PKAc is not required for the preerythrocytic stages of Plasmodium berghei

Hadi Hasan Choudhary, Roshni Gupta, View ORCID ProfileSatish Mishra  Correspondence email
Hadi Hasan Choudhary
1Division of Parasitology, CSIR-Central Drug Research Institute, Lucknow, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roshni Gupta
1Division of Parasitology, CSIR-Central Drug Research Institute, Lucknow, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Satish Mishra
1Division of Parasitology, CSIR-Central Drug Research Institute, Lucknow, India
2Academy of Scientific and Innovative Research, Ghaziabad, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Satish Mishra
  • For correspondence: satish.mishra@cdri.res.in
Published 29 May 2019. DOI: 10.26508/lsa.201900352
  • Article
  • Figures & Data
  • Info
  • Metrics
  • Reviewer Comments
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Supplementary Materials
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1. PKAc expression analysis and generation of conditional knockout parasites.

    (A) The gene expression of PKAc was analyzed by quantitative PCR that revealed high level of expression in the blood (Schz) and hepatic (LS 65) schizonts. The expression was normalized with P. berghei Hsp70. BS; blood stages, Schz; schizonts, MG Spz, midgut sporozoites, SG Spz; SG sporozoites. Data are shown as means ± SEM (n = 3). (B) a. Schematic representation of the PKAc wild-type locus. b. The targeting plasmid pPKAc/FRT contains 1.2-kb F1, including 5′UTR of PKAc, first exon, and part of the first intron of PKAc, followed by the first FRT site (red thick arrow); F2 representing 1.6-kb remaining part of the gene, TRAP 3′UTR (pink lollipop), human dihydrofolate reductase (hDHFR) cassette, and second FRT site (red thick arrow); and 0.53-kb F3 showing 3′UTR of the PKAc gene. 5′ and 3′ regulatory sequences are represented by an arrow and lollipop, respectively. PKAc 3′UTR (green lollipop) and P. berghei DHFR/TS 3′UTR (blue lollipop). c. Following successful double crossover homologous recombination (as indicated by the dotted lines), the wild-type locus was replaced by the targeting vector sequence. d. Excision of the flirted locus after passing through mosquito. (C) Replacement of the wild-type locus was verified by PCR using primers 1072/1216 and 1215/1073 for 5′ and 3′ site-specific integrations, respectively, and full cassette integration was confirmed using primers 1409/1073, which amplified 2.48 kb in TRAP/FlpL, whereas 4.8 kb in PKAc cKO. NTC, no template control. (D) Parasitemia of PKAc cKO in comparison with TRAP/FlpL in mice. Two groups of mice were injected intravenously with either TRAP/FlpL or PKAc cKO, and the blood stage growth was monitored by microscopic examination of Giemsa-stained blood smears. Data are shown as means ± SEM (n = 3). One-way ANOVA was used for statistical analysis (P = 0.997).

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2. PKAc is not required for parasite development in the mosquito.

    (A) Oocysts count per mosquito. One-way ANOVA was used for statistical analysis, and no difference in oocyst numbers was observed (P = 0.923). (B) Magnified oocyst showing sporulation. Scale bar, 25 μm. (C) Quantifications of the midgut (MG)-associated sporozoites. Data are shown as means ± SEM (n = 3). (D) PCR-based confirmation of flirted locus excision in PKAc cKO parasites using primers 1409-1073. Both excised and non-excised loci were amplified in PKAc cKO MG parasites, but only the intact PKAc locus was amplified from the blood stage (SC). (E) Quantifications of the SG-associated sporozoites. Data are shown as means ± SEM (n = 3). One-way ANOVA was used for statistical analysis for MG (P = 0.945) and SG (P = 0.806). Error bars represent SEM. (F) Flirted PKAc cKO locus excision was also monitored in SG and after infecting mice with sporozoites as described previously. The excised locus was amplified in PKAc cKO SG parasites, but only the intact PKAc locus was amplified from the blood stage (SC) parasites both before (SC) and after passing through mosquito (PPP). MG, midgut; NTC, no template control; PPP, prepatent period; SC, single clone.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3. Analysis of PKAc cKO sporozoites.

    (A) PKAc cKO sporozoites show normal CSP shedding and secretion in the medium. Hsp70 was used as the loading control. No difference was observed in three independent experiments. (B, C) Gliding motility of PKAc cKO sporozoites was similar to the gliding activity observed for TRAP/FlpL parasites. Scale bar, 25 μm. Representative data of three independent experiments. One-way ANOVA was used for statistical analysis for 1 (P = 0.358), 2–10 (P = 0.457), and >10 circles (P = 0.273). (D) Immunofluorescence assay showing inside/outside sporozoites by differential staining with CSP antibody before and after permeabilization in HepG2 cells. Outside sporozoites were stained before permeabilization with CSP antibody (CSP-R), and total sporozoites were stained after permeabilization (CSP-G). Scale bar, 25 μm. (E) Bar graph showing percent sporozoites inside versus outside. Data are shown as means ± SEM (n = 3) in which the total number of sporozoites counted were 2,332 (TRAP/FlpL), 3,527 (PKAc cKO c1) and 3,147 (PKAc cKO c2). One-way ANOVA was used for statistical analysis (P = 0.717).

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4. PKAc cKO parasites develop and egress normally in the liver.

    (A) To determine if PKAc cKO parasites develop and egress from the liver, infected mice livers were harvested at the indicated time points. The parasite burden in the liver was checked by amplifying the parasite 18S rRNA. Mice were treated with a combination of chloroquine, beginning 24 h after sporozoite injection, and artesunate, beginning 39 h after sporozoite injection, to prevent the growth of blood stage parasites. Therefore, the decrease of copy number between 55 and 72 h indicates a loss of liver-specific signal. This experiment was performed twice with similar results, and data from one experiment are presented. Unpaired two-tailed t test was used for statistical analysis for 36 h (P = 0.824), 55 h (P = 0.623), and 72 h (P = 0.493). (B) Development of PKAc cKO and TRAP/FlpL EEFs in vitro. HepG2 cells were infected with SG sporozoites, and the culture was harvested at different time points. Cultures removed at 36 h p.i. were fixed and parasites were detected using anti-Hsp70 and anti-UIS4 antibodies. Scale bar, 5 μm. (C) Quantification of EEF numbers at 36 h p.i.; no significant difference was observed in three independent experiments. One-way ANOVA was used for statistical analysis (P = 0.693). (D) Cultures removed at 62 h p.i. were probed with UIS4 and MSP1 to visualize PV membrane and formation of merozoites, respectively. Scale bar, 5 μm. (E) Quantitation of EEF area at 36 and 62 h p.i. The EEF size was similar in both PKAc cKO and TRAP/FlpL parasites. Unpaired two-tailed t test was used for statistical analysis for 36 (P = 0.406), and 62 h (P = 0.977). Error bars represent SD. To determine the size of the EEFs, the perimeter was delineated using the “region of interest” tool and the area was calculated using Nikon NIS elements BR imaging software.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5. Merosome development and excision of flirted PKAc locus.

    (A) PKAc cKO parasites released a similar number of merosomes in the culture supernatant as compared with TRAP/FlpL. Merosome experiments were performed three times with similar results, and data from one experiment are presented. Error bars represent SD. Unpaired two-tailed t test was used for statistical analysis (P = 0.104). (B) PKAc cKO merosomes show normal loss of the PV membrane and normal segregation of merozoite membranes. Scale bar, 5 μm. (C) Measurement of UIS4 intensity showing normal loss of PV membrane in PKAc cKO parasites. One-way ANOVA was used for statistical analysis (P = 0.481). (D, E) PCR-based confirmation of flirted locus excision in PKAc cKO parasites using primers 1409-1073. Genomic DNA was isolated from the TRAP/FlpL line and different stages of PKAc cKO parasites. The wild-type locus was amplified from the TRAP/FlpL line, and the excised locus was amplified in PKAc cKO SG, LS, and MS parasites, but only the intact PKAc locus was amplified from the blood stage (SC) parasites both before (SC) and after passing through mosquito (PPP). (F) Amplification of the non-excised region using internal primers 1409-1074. (G) Presence of FRT site in the amplified product was confirmed by XbaI digestion, which yielded 348- and 255-bp products.

  • Figure S1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure S1. STRING analysis.

    The STRING (https://string-db.org) interaction diagram of P. berghei shows interaction of PKAc with the cAMP-dependent protein kinase regulatory subunit (PBANKA_143800), PKG (PBANKA_100820), glideosome-associated protein 40 (PBANKA_111530), glideosome-associated protein 45 (PBANKA_143760), rhoptry neck protein 5 (PBANKA_071310), rhoptry-associated protein 1 (PBANKA_103210), guanylate cyclase beta (PBANKA_113670), guanylyl cyclase (PBANKA_091030), and leucine-rich repeat protein (PBANKA_090270). Of these proteins, PBANKA_111530 and PBANKA_071310 are reported to be essential for parasite blood stages, whereas PBANKA_103210, PBANKA_113670 and PBANKA_091030 deletions resulted in slow-growing parasites; PBANKA_090270 was found to be dispensable (data extracted from PlasmoGEM, http://plasmogem.sanger.ac.uk/phenotypes; Bushell et al (2017)).

Tables

  • Figures
  • Supplementary Materials
    • View popup
    Table 1.

    Infectivity of PKAc cKO sporozoites in C57BL/6 mice

    ExperimentParasiteNumber of sporozoites injectedMice positive/mice injectedPrepatent period (day)
    1TRAP/FlpL5,0004/43
    PKAc cKO c15,0005/56
    2TRAP/FlpL5,0002/23
    PKAc cKO c15,0003/46
    3TRAP/FlpL5,0002/23
    PKAc cKO c25,0004/46
    • Mice were inoculated i.v. with PKAc cKO or TRAP/FlpL sporozoites. Blood smears were examined daily day 3 p.i., and mice were considered negative if parasites were not detected by day 30.

    • View popup
    Table 2.

    PKAc cKO merosomes have impaired infectivity in mice

    ExperimentParasiteNumber of merosomes injectedMice positive/mice injectedPrepatent period (d)
    1TRAP/FlpL15/55.6
    PKAc cKO c110/5NA
    TRAP/FlpL105/52.2
    PKAc cKO c1100/5NA
    2TRAP/FlpL105/52
    PKAc cKO c1100/5NA
    TRAP/FlpL10 mr5/52.4
    PKAc cKO c110 mr0/5NA
    TRAP/FlpL1005/51.4
    PKAc cKO c11005/54.4
    TRAP/FlpL100 mr5/51.6
    PKAc cKO c1100 mr5/55.6
    3TRAP/FlpL1005/51.2
    PKAc cKO c11005/55.2
    TRAP/FlpL100 mr5/51.4
    PKAc cKO c1100 mr5/56.2
    • Swiss mice were inoculated i.v. with the indicated number of merosomes with or without mechanical rupture (mr). Blood smears were examined daily as described previously.

Supplementary Materials

  • Figures
  • Tables
  • Table S1 STRING analysis showing proteins with direct or indirect interaction with P. berghei PKAc along with their PlasmoGEM and RMgmDB phenotypes.

  • Supplemental Data 1.

    [LSA-2019-00352_Supplemental_Data_1.doc]

  • Table S2 List of primers used in this study.

PreviousNext
Back to top
Download PDF
Email Article

Thank you for your interest in spreading the word on Life Science Alliance.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
PKAc is not required for the preerythrocytic stages of Plasmodium berghei
(Your Name) has sent you a message from Life Science Alliance
(Your Name) thought you would like to see the Life Science Alliance web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
PKAc is dispensable in Plasmodium preerythrocytic stages
Hadi Hasan Choudhary, Roshni Gupta, Satish Mishra
Life Science Alliance May 2019, 2 (3) e201900352; DOI: 10.26508/lsa.201900352

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
PKAc is dispensable in Plasmodium preerythrocytic stages
Hadi Hasan Choudhary, Roshni Gupta, Satish Mishra
Life Science Alliance May 2019, 2 (3) e201900352; DOI: 10.26508/lsa.201900352
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
Issue Cover

In this Issue

Volume 2, No. 3
June 2019
  • Table of Contents
  • Cover (PDF)
  • About the Cover
  • Masthead (PDF)
Advertisement

Jump to section

  • Article
    • Abstract
    • Introduction
    • Results
    • Discussion
    • Materials and Methods
    • Acknowledgements
    • References
  • Figures & Data
  • Info
  • Metrics
  • Reviewer Comments
  • PDF

Subjects

  • Cell Biology
  • Microbiology, Virology & Host Pathogen Interaction
  • Molecular Biology

Related Articles

  • No related articles found.

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Ocular blood flow reduction promote RGC loss
  • AURKA phosphorylation of HEC1 in oocytes
  • SLC38A9 in Tat-induced senescence
Show more Research Article

Similar Articles

EMBO Press LogoRockefeller University Press LogoCold Spring Harbor Logo

Content

  • Home
  • Newest Articles
  • Current Issue
  • Archive
  • Subject Collections

For Authors

  • Submit a Manuscript
  • Author Guidelines
  • License, copyright, Fee

Other Services

  • Alerts
  • Bluesky
  • X/Twitter
  • RSS Feeds

More Information

  • Editors & Staff
  • Reviewer Guidelines
  • Feedback
  • Licensing and Reuse
  • Privacy Policy

ISSN: 2575-1077
© 2025 Life Science Alliance LLC

Life Science Alliance is registered as a trademark in the U.S. Patent and Trade Mark Office and in the European Union Intellectual Property Office.